The way we conduct clinical trials is, and will continue to be, an evolution – developing and mirroring advancements in healthcare, technology and patient perspectives. While the past 2 years put a spotlight on clinical trials and the restrictions of hospital-focused healthcare to the general public, the need to decentralize and bring clinical trials to patients was noted by the pharmaceutical industry long before the pandemic. Read below to discover the tipping point for cost effective implementation.
